Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Diagnosis and treatment of acromegaly 18th Annual National Cooperative Growth Study/5th Annual National Cooperative Somatropin Surveillance Investigator Meeting Katznelson, L. CHURCHILL LIVINGSTONE. 2005: S31–S35

Abstract

Acromegaly is an insidious disease that occurs, in the majority of cases, as a result of a pituitary adenoma that hypersecretes growth hormone (GH). The clinical consequences of acromegaly are a function of excess GH secretion and mass effect of the pituitary tumor. The involvement of multiple organ systems may lead to significant morbidity and mortality, prompting the need for rapid and accurate disease recognition and treatment. This brief review will describe current recommendations for management of this uncommon, but debilitating, endocrine disorder.

View details for Web of Science ID 000231443900008

View details for PubMedID 16023876